C$101 Million (cad)

MedReleaf Corporation

Initial Public Offering

Lead Manager, May 2017

MedReleaf is a Canadian Licensed Producer (“LP”) of cannabis-based pharmaceutical products based in Markham, Ontario. The Company is licensed by Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulation (“ACMPR”) to, among other things, produce at its Markham Facility an aggregate of up to 6,000 kilograms of dried cannabis and up to 1,760 kilograms of cannabis oil, and to sell and distribute within Canada an aggregate of up to 5,000 kilograms of dried cannabis, up to 1,319 kilograms of bottled cannabis oil, and up to 440 kilograms of encapsulated cannabis oil produced at its Markham Facility, pursuant to the Markham Commercial License. MedReleaf cultivates and produces its cannabis-based pharmaceutical products for direct sales to its patients from the Markham Facility across Canada. The Company interacts with its patients via its e-commerce platform as well as by phone and email correspondence directed to its patientcare team. Additionally, the Company has completed phase I construction of its Bradford Facility, which has a targeted minimum annual cultivation capacity of 28,000 kilograms.